Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …

The recent outbreak of coronavirus disease 2019 (COVID‐19), caused by the Severe Acute
Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) has resulted in a world‐wide …

Methods: We describe the clinical course and histologic features of 3 adults who developed
prolonged and severe cholestasis during recovery from critical cardiopulmonary COVID-19 …

Common manifestations of COVID-19 are respiratory and can extend from mild symptoms to
severe acute respiratory distress. The severity of the illness can also extend from mild …

Abstract Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), continues to spread globally despite the worldwide …

METHODS: We conducted a retrospective study of COVID-19 patients admitted to our
institution from March 1, 2020, to August 15, 2020, on whom the hepatology service was …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first identified in
December 2019 as a novel respiratory pathogen and is the causative agent of Corona Virus …

The aim of this document is to provide a concise scientific review of the currently available
COVID‐19 vaccines and those in development, including mRNA, adenoviral vectors, and …

Occurrence of hyperglycemia upon infection is associated with worse clinical outcome in
COVID-19 patients. However, it is still unknown whether SARS-CoV-2 directly triggers …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has undoubtedly
revolutionized the whole globe and given a new point of view on respiratory tract infections …